Purpose of the Institutional Biosafety Committee

Kennesaw State University (KSU) is committed to the highest standards of safe and ethical research and complies with all federal, state, local laws and regulations and University System of Georgia policies. For this purpose and to comply with the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), KSU has established an Institutional Biosafety Committee (IBC). The NIH Guidelines apply to all recombinant DNA research that is conducted at or sponsored by any institution that receives support from the NIH.  Thus these guidelines apply to everyone who participates in research, instruction, or work at KSU.

Click here for the IBC Charter.

Scope and Oversight of the Institutional Biosafety Committee

The IBC is responsible for local oversight and review of activities that use the following potentially bio-hazardous materials or procedures:

  • Recombinant or synthetic nucleic acid molecules (rDNA/RNA)
  • Select agents and toxins, as determined by the Federal Select Agent Program
  • Biological agents that require Biosafety Level 2 containment or higher, including
    • Agents in Risk Group 2, 3, and 4
    • Blood borne pathogens (from human and non-human primates)
    • All other biological agents that can cause disease in humans
  • Stem cell research
  • Biological Nanotechnology (e.g., drug delivery via nanoparticles, etc.)
  • Importing/Exporting of etiologic agents (which require BSL-2 and or BSL-3 containment) into/out of the campus
  • Xenotransplantation